期刊文献+

胃癌及癌旁组织Fas、Fas L的表达 被引量:3

The Expression of Fas,Fas L in Gastric Cancer and Adjacent Noncancerous Tissues
原文传递
导出
摘要 目的 :探讨细胞凋亡相关蛋白的Fas、FasL在胃癌发生、发展中的作用。方法 :对 74例手术切除胃癌标本 ,应用免疫组化S P法检测Fas、FasL蛋白在癌组织和相应癌旁组织中的表达。结果 :在高中分化型胃癌Fas和FasL的阳性表达率一致性显著高于低分化型胃癌 (P <0 0 5 )。而在早期和进展期胃癌间 ,有淋巴结转移和无淋巴结转移胃癌间Fas和FasL的阳性表达率无显著性差异 (P >0 0 5 )。胃癌组织Fas阳性表达率显著低于癌旁组织 (P <0 0 5 )。FasL在两者间无显著性差异 (P >0 0 5 )。结论 :Fas和FasL的异常表达可能是胃粘膜癌变过程中细胞凋亡抑制的重要机制之一 ,并与胃癌的分化和免疫逃逸有关。 Purpose: To study the relationship between the expression of Fas and Fas L protein and the pathogenesis and devolopment of gastric cancer. Methods: The expression of Fas and Fas L protein were exammed by S P immunohistochemistry. Results: The expression of Fas and Fas L was correlated with the degree of differentiation, but not correlated with the depth of invasion and metastasis of lymph node. The positive rate of Fas in gastric cancer was significantly lower than the adjacent noncancerous tissue. But the expression of Fas L wasn't significantly different in gastric cancer and the adjacent noncancerous tissue. Conclusion: The abnormal expression of Fas and Fas L maybe involve in the pathogenesis and the immune escape of gastric cancer, and also in the degree of differentiation.
出处 《临床消化病杂志》 2002年第1期9-11,共3页 Chinese Journal of Clinical Gastroenterology
关键词 胃癌 FAS FASL 癌旁组织 表达 Gastric cancer Fas Fas L
  • 相关文献

参考文献10

  • 1Suda T, Takahashi T, Golstein P, et al. Molecular cloning and expression of the Fas L: a novel member of the tumor necrosis factor family. Cell, 1993,75: 1169
  • 2Green DR. Apoptosis pathway: the road to ruin. Cell, 1998,94:695.
  • 3贾百灵,李继昌,黄河,李修岭.胃腺癌发生过程中Fas、Bcl-2、Bax蛋白表达的变化[J].中华消化杂志,1999,19(4):267-268. 被引量:11
  • 4Rudi J, Kuck D, Strand S, et al. Involvement of the CD95 (Apo-1/Fas) receptor and ligand system in helicobacter pylori induced gastric epithelial apoptosis. J Clin Invest, 1998,102: 1506.
  • 5Compagni A, Christofori G. Recent advances in research on mutistage tumorigenesis. British Joural of Canecr,2000,83: 1.
  • 6刘海峰,刘为纹,房殿春,门荣甫.胃癌和癌旁组织中Fas抗原表达与细胞凋亡的关系[J].华人消化杂志,1998,6(4):321-322. 被引量:19
  • 7O' connell J, Benentt MW, O'sullivan GC, et al. The Fas counterattack: cancer cell a site of imunume privilige immunology.Today, 1999,20: 46.
  • 8高勇,张登海.Fas系统与肿瘤免疫逃逸[J].国外医学(肿瘤学分册),1998,25(6):327-329. 被引量:13
  • 9Bennett MW, O'connell J, O'sullivan GC, et al. Expression of Fas ligand by human gastric adcnocarcinomas, a potential mechanism of immune escape in stomach cancer. Gut, 1999,44:156.
  • 10.Kume T, Oshima K, Yamashita Y, et al. Relationship betwecn Fas ligand expression on carcinoma cell and cytotoxic T-lymphocyte response in lymphoepitheliamatike cancer of the stomach. Int J Cancer, 1999,84: 339.

二级参考文献2

  • 1张荫昌 中华人民共和国医政司.胃粘膜病变的诊断标准.中国常见恶性肿瘤诊疗规范,第2版[M].北京:北京医科大学中国协和医科大学联合出版社,1991.34-42.
  • 2张荫昌,中国常见恶性肿瘤诊治规范(第2版),1991年,34页

共引文献39

同被引文献39

  • 1李虹,郑世营,赵军,蒋东,张晓膺.肺癌Fas表达水平与抗Fas治疗生物学效应关系的研究[J].南通大学学报(医学版),2008,28(6):427-429. 被引量:3
  • 2毕蔓茹,杨宝山,马英骥,陈立艳,王岩,高峰,王福祥.复方甘草酸苷对小鼠暴发性肝衰竭Fas/FasL介导的肝细胞凋亡的保护作用[J].世界华人消化杂志,2005,13(1):26-30. 被引量:12
  • 3向青,徐波,徐梅.Fas/FasL途径介导的人肺癌细胞免疫逃逸[J].中国病理生理杂志,2006,22(1):168-171. 被引量:15
  • 4Alessandro S, Robert C ,John F. HLA expression in cancer : Implications for T-cell based immunotherary [J]. Immunogeneties,2001,53(4) :255.
  • 5Sophie L, Martine A, Serge U,et al. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer[J]. Journal of Pathology, 2002,196 (3) ; 266.
  • 6Botti C, Seregni E, Ferraxi L, et al. Immunosuppressive factors:role in cancer development and progression[J]. Int J Biol Markers, 1998,13(2) :51.
  • 7Peter CR. Emtage, Yonghong Wan, Jonathan L, et al. A double recombinant adenovirus expressing the costimulatory molecule B7-1(Murine)and human IL-2 induces complete tumor regression in a murine breast adenocareinoma model [J]. The Journal of Immonology, 1998,160(5) :2531.
  • 8Dong H, Strome SE, Salomao DR, et al. Tumor-associated B7-H1 promotes T-cell apoptosis : a potential mechanism of immune evasion[J]. Nat Med, 2002,8 (8) : 793.
  • 9Jodo S,Kobayashi S,Nakajima Y,et al. Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma[J]. Clin Exp Immunol, 1998,112(2) : 166.
  • 10Kareela PI ,Green SJ ,Bowden SJ ,et al. Identification of a binding site for intergrin alpha E beta(7) in the N-terminal domain of Ecadherin[J] .J Biol Chem, 1996,271(48):30909.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部